Table 3 Predictors associated with good long-term outcome after undergoing mechanical thrombectomy assessed by telephone and dichotomized EQ mobility score by the EQ-5D-5L (score 1 or 2 versus greater than or equal to 3)

Age

63.4 ± 14.9

71.9 ± 14.5

U = 1841.000, Z = 3.399, p < 0.001^c

Aetiology of stroke

 LAAS

9 (18.0%)

4 (8.2%)

 CES

18 (36.0%)

31 (63.3%)

 Other

5 (10.0%)

5 (10.2%)

 Cryptogenic stroke

18 (36.0%)

9 (18.4%)

8.363/0.039^a

 CES

18/50 (36.0%)

31/49 (63.3%)

7.360/0.007^a

Severity indices on admission

 NIHSS after 24 h

5.7 ± 5.6

10.8 ± 7.4

U = 1273.500, Z = 3.561, p < 0.001^c

Median: 4

Median: 8

 Delta NIHSS baseline to 24 h ≥ 8

20/42 (47.6%)

7/37 (18.9%)

7.202/0.007^a

 NIHSS ≤ 10 after 24 h

37/45 (82.2%)

22/39 (56.4%)

6.659/0.010^a

Thrombectomy parameters

 Thrombectomy technique

  Stentimplantation

13/51 (25.5%)

4/52 (7.7%)

5.918/0.015^a

Risk factors

 Blood glucose level on admission

130.6 ± 56.3 mg/dl

133.4 ± 28.3 mg/dl

U = 1535.000, Z = 1.969, p = 0.049^c

 Cholesterol level on admission

184.8 ± 43.8 mg/dl

164.9 ± 35.6 mg/dl

U = 907.000, Z = 2.365, p = 0.018^c

 LDL level on admission

121.4 ± 42.1 mg/dl

102.6 ± 32.1 mg/dl

U = 934.000, Z = 2.179, p = 0.029^c

 Statine therapy on admission

7/37 (18.9%)

17/39 (43.6%)

5.349/0.021^a

Atrial fibrillation

13/51 (25.5%)

31/52 (59.6%)

12.253 / < 0.001^a

 Former stroke

6/51 (11.8%)

16/52 (30.8%)

5.536/0.019^a

Oral anticoagulation on admission

1/51 (2.0%)

8/52 (15.4%)

5.818/0.016^a

(INR >  = 1.7) or (AntiXa >  = 0.4 IU/ml) or (thrombin time >  = 42 s)

Complications

 Infection within 72 h

18/51 (35.3%)

35/52 (67.3%)

10.564/0.001^a

 Recent therapy

 Antiaggregant therapy at telephone interview

29/50 (58.0%)

18/51 (35.3%)

5.232/0.022^a

 Oral anticoagulation at telephone interview

18/51 (35.3%)

32/51 (62.7%)

7.689/0.006^a